Quarterly report pursuant to Section 13 or 15(d)

Selected Balance Sheet Data

v3.24.0.1
Selected Balance Sheet Data
6 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Selected Balance Sheet Data

Note 3. Selected Balance Sheet Data:

Inventories:

Inventories consist of (in thousands):

​

​

​

​

​

​

​

​

​

    

December 31, 

​

June 30, 

​

    

2023

    

2023

​

​

​

​

​

​

​

Raw materials

​

$

83,247

​

$

84,551

Finished goods(1)

​

 

102,907

​

 

92,474

Inventories, net

​

$

186,154

​

$

177,025

​

(1) Finished goods inventory of $5,315 and $5,387 included within Other long-term assets in the respective December 31, 2023 and June 30, 2023, Consolidated Balance Sheet. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date.

Property and Equipment:

Property and equipment consist of (in thousands):

​

​

​

​

​

​

​

​

​

    

December 31, 

​

June 30, 

​

    

2023

    

2023

Land

​

$

8,180

​

$

9,100

Buildings and improvements

​

 

243,640

​

 

245,302

Machinery and equipment

​

​

199,533

​

​

190,019

Construction in progress

​

 

28,065

​

 

15,491

Property and equipment, cost

​

 

479,418

​

 

459,912

Accumulated depreciation and amortization

​

 

(245,214)

​

 

(233,712)

Property and equipment, net

​

$

234,204

​

$

226,200

​

Intangible Assets:

Intangible assets consist of (in thousands):

​

​

​

​

​

​

​

​

​

​

December 31, 

​

June 30, 

​

​

2023

​

2023

​

​

​

​

​

​

​

Developed technology

​

$

657,192

​

$

616,311

Trade names

​

 

152,206

​

 

146,945

Customer relationships

​

 

211,733

​

 

213,878

Patents

​

 

4,080

​

 

3,815

Other intangibles

​

 

11,865

​

 

11,566

Definite-lived intangible assets

​

 

1,037,076

​

 

992,515

Accumulated amortization

​

 

(509,171)

​

 

(480,570)

Definite-lived intangibles assets, net

​

 

527,905

​

 

511,945

In process research and development

​

 

22,700

​

 

22,700

Total intangible assets, net

​

$

550,605

​

$

534,645

​

​

Changes to the carrying amount of net intangible assets for the period ended December 31, 2023 consist of (in thousands):

​

​

​

​

​

​

​

​

​

Beginning balance

​

$

534,645

Acquisitions

​

 

66,400

Other additions

​

 

556

Held-for-sale intangibles(1)

​

​

(14,323)

Amortization expense

​

 

(40,383)

Currency translation

​

​

3,710

Ending balance

​

$

550,605

​

(1) Refer to Note 1 for further detail on held-for-sale intangibles.

​

The estimated future amortization expense for intangible assets as of December 31, 2023 is as follows (in thousands):

​

​

​

​

​

Remainder 2024

    

$

39,332

2025

​

 

75,553

2026

​

 

71,575

2027

​

 

61,394

2028

​

 

57,733

Thereafter

​

 

222,318

Total

​

$

527,905

​

Goodwill:

​

Changes to the carrying amount of goodwill for the period ended December 31, 2023 consist of (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Diagnostics and

    

​

​

​

Protein Sciences

​

 Genomics

​

Total

June 30, 2023

​

$

427,027

​

$

445,710

​

$

872,737

Acquisitions

​

 

—

​

​

102,546

​

​

102,546

Held-for-sale goodwill(1)

​

​

(1,400)

​

​

—

​

​

(1,400)

Currency translation

​

 

318

​

​

5,881

​

​

6,199

December 31, 2023

​

$

425,945

​

$

554,137

​

$

980,082

​

(1)Refer to Note 1 for further detail on goodwill reclassified to current assets held-for-sale.

​

We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a qualitative goodwill impairment assessment for all of its reporting units during the fourth quarter of fiscal 2023. No indicators of impairment were identified as part of our assessment.

​

Other Assets:

​

Other assets consist of (in thousands):

​

​

​

​

​

​

​

​

​

    

December 31, 

​

June 30, 

​

    

2023

​

2023

​

​

​

​

​

​

​

Investment in Wilson Wolf

​

$

249,730

​

$

255,857

Derivative instruments

​

​

11,589

​

​

16,857

Long-term inventory

​

​

5,315

​

​

5,387

Other

​

 

7,725

​

 

7,201

Other assets

​

$

274,359

​

$

285,302

​